Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 175

1.

Psoriatic arthritis and psoriasis projects in Italy: a report from the GRAPPA 2011 annual meeting.

Cauli A, Lubrano E, Scarpa R, Olivieri I.

J Rheumatol. 2012 Nov;39(11):2201-3. doi: 10.3899/jrheum.120824.

PMID:
23118288
[PubMed - indexed for MEDLINE]
2.

Prologue: 2011 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).

Mease PJ, Gladman DD.

J Rheumatol. 2012 Nov;39(11):2181-3. doi: 10.3899/jrheum.120818.

PMID:
23118282
[PubMed - indexed for MEDLINE]
3.

Prologue: 2012 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).

Mease PJ, Boehncke WH, Gladman DD.

J Rheumatol. 2013 Aug;40(8):1407-9. doi: 10.3899/jrheum.130450.

PMID:
23908533
[PubMed - indexed for MEDLINE]
4.

Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists' perspective: a report from the GRAPPA 2011 annual meeting.

Armstrong AW, Callis Duffin K, Garg A, Gelfand JM, Gottlieb AB, Krueger GG, Qureshi AA, Rosen CF.

J Rheumatol. 2012 Nov;39(11):2204-10. doi: 10.3899/jrheum.120825.

PMID:
23118289
[PubMed - indexed for MEDLINE]
5.

TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.

Tobin AM, Kirby B.

BioDrugs. 2005;19(1):47-57. Review.

PMID:
15691217
[PubMed - indexed for MEDLINE]
6.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

PMID:
16948890
[PubMed - indexed for MEDLINE]
Free Article
7.

GRAPPA Trainees Symposium 2011: a report from the GRAPPA 2011 annual meeting.

Ash Z, Ritchlin CT.

J Rheumatol. 2012 Nov;39(11):2184-8. doi: 10.3899/jrheum.120819.

PMID:
23118283
[PubMed - indexed for MEDLINE]
8.

Composite Measures in Psoriatic Arthritis: a report from the GRAPPA 2009 annual meeting.

Helliwell PS, Fitzgerald O, Strand CV, Mease PJ.

J Rheumatol. 2011 Mar;38(3):540-5. doi: 10.3899/jrheum.101116.

PMID:
21362782
[PubMed - indexed for MEDLINE]
9.

Development of composite measures for psoriatic arthritis: a report from the GRAPPA 2010 annual meeting.

Helliwell PS, Fitzgerald O, Mease PJ.

J Rheumatol. 2012 Feb;39(2):398-403. doi: 10.3899/jrheum.111233.

PMID:
22298265
[PubMed - indexed for MEDLINE]
10.

Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).

Boehncke WH, Gladman DD.

J Rheumatol. 2014 Jun;41(6):1194-6. doi: 10.3899/jrheum.140168.

PMID:
24882850
[PubMed - indexed for MEDLINE]
11.

Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression.

Mease PJ, Kivitz AJ, Burch FX, Siegel EL, Cohen SB, Ory P, Salonen D, Rubenstein J, Sharp JT, Tsuji W.

Arthritis Rheum. 2004 Jul;50(7):2264-72.

PMID:
15248226
[PubMed - indexed for MEDLINE]
Free Article
12.

Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis.

Krueger G, Callis K.

Arch Dermatol. 2004 Feb;140(2):218-25. Review.

PMID:
14967799
[PubMed - indexed for MEDLINE]
13.

Psoriasis and psoriatic arthritis in Peruvian aborigines: a report from the GRAPPA 2011 annual meeting.

Toloza SM, Vega-Hinojosa O, Chandran V, Valle Onate R, Espinoza LR.

J Rheumatol. 2012 Nov;39(11):2216-9. doi: 10.3899/jrheum.120828.

PMID:
23118292
[PubMed - indexed for MEDLINE]
14.

Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial.

Prinz JC, Fitzgerald O, Boggs RI, Foehl J, Robertson D, Pedersen R, Molta CT, Freundlich B.

J Eur Acad Dermatol Venereol. 2011 May;25(5):559-64. doi: 10.1111/j.1468-3083.2010.03838.x. Epub 2010 Sep 14.

PMID:
20840349
[PubMed - indexed for MEDLINE]
15.

On defining musculoskeletal inflammation: a report from the GRAPPA 2011 annual meeting.

Garg A, Gladman DD, Mease PJ.

J Rheumatol. 2012 Nov;39(11):2214-5. doi: 10.3899/jrheum.120827.

PMID:
23118291
[PubMed - indexed for MEDLINE]
16.

The need to define musculoskeletal inflammation: a report from the GRAPPA 2010 annual meeting.

Garg A, Gladman DD, Mease PJ.

J Rheumatol. 2012 Feb;39(2):413-4. doi: 10.3899/jrheum.111236.

PMID:
22298268
[PubMed - indexed for MEDLINE]
17.

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.

Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ.

Lancet. 2000 Jul 29;356(9227):385-90.

PMID:
10972371
[PubMed - indexed for MEDLINE]
18.

Etanercept: an evolving role in psoriasis and psoriatic arthritis.

Prodanovich S, Ricotti C, Glick BP, Inverardi L, Leonardi CL, Kerdel F.

Am J Clin Dermatol. 2010;11 Suppl 1:3-9. doi: 10.2165/1153413-S0-000000000-00000. Review.

PMID:
20586498
[PubMed - indexed for MEDLINE]
19.

Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens.

Gniadecki R, Robertson D, Molta CT, Freundlich B, Pedersen R, Li W, Boggs R, Zbrozek AS.

J Eur Acad Dermatol Venereol. 2012 Nov;26(11):1436-43. doi: 10.1111/j.1468-3083.2011.04308.x. Epub 2011 Oct 31.

PMID:
22035157
[PubMed - indexed for MEDLINE]
20.

Psoriasis and psoriatic arthritis video project: an update from the GRAPPA 2011 annual meeting.

Callis Duffin K, Armstrong AW, Mease PJ.

J Rheumatol. 2012 Nov;39(11):2198-200. doi: 10.3899/jrheum.120823.

PMID:
23118287
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk